Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland.
The International Journal of Neuropsychopharmacology June 2, 2026 John R. Kelly, Christopher Sheridan, Patricia Iusan et al.
Classical serotonergic psychedelics, such as psilocybin, show emerging evidence of therapeutic potential across a range of mental health disorders, including depression, anxiety, and substance use disorders, with indications of transdiagnostic efficacy. While early-phase studies yielded encouraging results, recent larger-scale phase 3 trials, such as those evaluating psilocybin for...